TIXT Investors Have Opportunity to Lead TELUS International (Cda) Inc. Securities Fraud Lawsuit with the Schall Law Firm – TELUS Intl (NYSE:TIXT)

Photo of author

By Ronald Tech

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against TELUS International (Cda) Inc. (“Telus” or “the Company”) TIXT for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between February 16, 2023 to August 01, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before March 31, 2025.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. The AI Data Solutions developed by Telus required the cannibalization of higher-margin offerings. The Company’s declining profitability was directly tied to its AI development. The Company’s shift to AI placed pressure on its margins. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Telus, investors suffered damages.

Join the case to recover your losses.

See also  Defensive Dividend Stocks Offering Stability Amid Pre-Election VolatilityExploring Zoetis - A Defensive Dividend Stock

As the U.S. presidential election fast approaches, investor anxieties are reaching a fever pitch like an orchestra building up to a crescendo. In such times of market tumult, seeking refuge in defensive dividend stocks can be akin to finding a sturdy lifeboat in a stormy sea.

The Resilient Rise of Zoetis

Among the entities that stand out in this defensive arena is Zoetis Inc., a stalwart player in the realm of animal health. With a legacy spanning over seven decades, Zoetis has become a beacon of stability in a sea of market fickleness, akin to a lighthouse guiding ships through rough waters.

A Fortified Fortress

Despite a YTD dip of 4%, Zoetis has clung tenaciously to its pillars of stability amidst the tumultuous market winds. The company's market cap looms large at around $85.1 billion, offering an anchor of steadfastness when the market tides turn rough.

A Flourishing Haven

Zoetis' five-year streak of consecutive dividend increases speaks volumes about its resilience. The company sails ahead, paying out a quarterly dividend of $0.432 per share with an annualized dividend of $1.73 per share.

Visionary Leadership and Financial Prowess

In August, Zoetis made waves as it surpassed all expectations with its second-quarter earnings. Like an eagle soaring high above the clouds, the company posted a revenue of $2.4 billion, signaling an 8% rise from the previous year—a testament to its unyielding spirit in the face of adversity.

The Bright Horizon

Guided by CEO Kristin Peck's steady hand, Zoetis raised its fiscal 2024 guidance with the confidence of a sure-footed mountaineer conquering new heights. The company anticipates revenue growth between $9.10 billion and $9.25 billion, paving the way for a brighter future.

The Astounding Acclaim and Future Projections

With a resounding consensus of "Strong Buy" ratings from analysts, Zoetis stands as a paragon of excellence in the eyes of the market. The price targets put forth a promising future, with a potential upside of 15.7% from current levels.

Diving into Kenvue - A Shield Against Turbulence

Turning our gaze to another bastion of stability, Kenvue Inc. emerges as a formidable contender in the landscape of consumer health, a shield repelling the arrows of uncertain market forces.

The Sturdy Bulwark

With a rich heritage dating back over a century, Kenvue boasts a diversified portfolio of trusted brands, standing strong with a market cap of $43.1 billion. The stock has surged 23% in the past three months, outshining broader market indices like a gleaming beacon in the night sky.

Ensuring Growth and Stability

Kenvue's recent dividend increase underscores its unwavering commitment to shareholders, offering $0.205 per share and a hearty 3.64% yield. This move aligns with the company's endeavor to drive sustainable growth and provide a steady hand amid market turmoil.

Financial News: Unlocking the Performance of Kenvue and American Water Works Unlocking the Performance of Kenvue and American Water Works

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

The Schall Law Firm

Brian Schall, Esq.

www.schallfirm.com

Office: 310-301-3335

info@schallfirm.com

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Momentum9.80

Growth18.76

Quality

Value35.17

Market News and Data brought to you by Benzinga APIs